If we get a good PR for PFS results and price pops to $5 or more I'll sell a small percentage. Partnership and another increase in PPS, take more profits. Most likely around half.
If it plays out like this I will most likely hold half through FDA and most likely wait for Tesetaxel.
That's the obvious play book. Now price structure could change rapidly. Other positive news like, but not excluded to EMEA approval, or CLL ?, and all bets off.
If for some reason Agenda is positive yet Ray doesn't want to receive any offers till FDA. Then needs more money after the first of the year and strikes up another crap financing deal I'm out. (very douthtful)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.